1981
DOI: 10.1016/s0140-6736(81)92190-5
|View full text |Cite
|
Sign up to set email alerts
|

Application of Human Leucocyte Interferon in Patients With Carcinoma of the Uterine Cervix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

1986
1986
2011
2011

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(8 citation statements)
references
References 2 publications
0
8
0
Order By: Relevance
“…In future, this therapy may become relevant in the management of oral cancers with N0 neck. These biological response modifiers occur naturally in the body but they can also be produced in the laboratory [72,78]. These agents include interferons, interleukins, colony-stimulating factors, monoclonal antibodies, vaccines, gene therapy and nonspecific immune-modulating agents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In future, this therapy may become relevant in the management of oral cancers with N0 neck. These biological response modifiers occur naturally in the body but they can also be produced in the laboratory [72,78]. These agents include interferons, interleukins, colony-stimulating factors, monoclonal antibodies, vaccines, gene therapy and nonspecific immune-modulating agents.…”
Section: Discussionmentioning
confidence: 99%
“…These agents include interferons, interleukins, colony-stimulating factors, monoclonal antibodies, vaccines, gene therapy and nonspecific immune-modulating agents. Their exact mechanism of action is not fully known but they are thought to boost the power of the immune system to destroy or kill cancer cells such as T cells, NK cells and macrophages, make cancer cells more recognizable by the immune system, stop the process which changes normal cells to cancer cells, enhance the body system to repair or replace damaged normal cells and also keep the cancer cells from spreading to other parts of the body [72,78,89].…”
Section: Discussionmentioning
confidence: 99%
“…The use of interferon for HPV-related diseases was actually begun before DNA hybridization studies confirmed virus involvement, Clinical investigations of crude human leukocyte interferon (HLI) were conducted at the Institute of Immunology in Zagreb, Yugoslavia, in the 1970's (28)(29)(30)(31)(32). Early clinical trials involved the treatment of some malignant tumors, including invasive squamous cell carcinoma and precancerous states of the uterine cervix.…”
Section: History Of Interferon Usage Early Milestonesmentioning
confidence: 99%
“…No pathologic progression was detected during the two year period of observation. In contrast, the lesions of control patients demonstrated malignant progression (30,31), Cancer studies were organized into three phases. In Phase I, intralesional injections were administered to 10 patients with cervical cancer and changes were monitored cytologically and histologically (32).…”
Section: History Of Interferon Usage Early Milestonesmentioning
confidence: 99%
See 1 more Smart Citation